Tag: Dr Anil Koul
JNU’s SCMM silver jubilee event spotlights future of molecular medicine
The national symposium focused on cutting-edge research, with Prof. Anil Koul delivering the prestigious B. K. Bachhawat Memorial Lecture on breakthroughs in tuberculosis drug discovery
India’s Push for Eradicating Tuberculosis
The Indian government continues to intensify efforts to diagnose and treat tuberculosis (TB), particularly in high-burden states like Uttar Pradesh, which has launched specialized programs to complement national initiatives
Digitally powered smart labs are the future of biopharma R&D: Experts
Leading biopharmaceutical scientists and industry leaders shared their valuable insights at the e-Conference on ‘Digital Laboratories: The Emerging Era of High-Tech R&D’ organized by BioVoice News on March 30, 2022
CSIR-IMTECH & ILBS sign MoU to treat liver ailments with alternative...
Under the Memorandum of Understanding signed by the Institute of Liver and Biliary Sciences and CSIR-Institute of Microbial Technology, both the institutes will collaborate to conduct microbiome research and perform clinical trials on patients affected with Severe Alcoholic Hepatitis..................
CSIR’s new clot buster, PEGylated Streptokinase holds great promise for brain...
Developed by the Chandigarh based CSIR-IMTECH, the patented PEGylated Streptokinase for treatment of Ischemic Stroke will be further developed and marketed by Epygen Biotech, Mumbai under an exclusive agreement……………….
Johnson & Johnson partners CSIR-IMTECH to develop new TB drugs
Memorandum of Understanding brings together best scientists from India and Johnson & Johnson to increase level and accelerate pace of innovation needed to make Tuberculosis history.......